Century Therapeutics Faces Delisting Concerns
Ticker: IPSC · Form: 8-K · Filed: Feb 28, 2025 · CIK: 1850119
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Century Therapeutics might get delisted - big trouble ahead.
AI Summary
Century Therapeutics, Inc. filed an 8-K on February 28, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on February 26, 2025. The company is incorporated in Delaware and its principal executive offices are located in Philadelphia, Pennsylvania.
Why It Matters
This filing indicates potential issues with Century Therapeutics' continued listing on an exchange, which could impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can lead to severe stock price declines and operational challenges.
Key Players & Entities
- Century Therapeutics, Inc. (company) — Registrant
- February 26, 2025 (date) — Earliest event reported
- February 28, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Philadelphia, Pennsylvania (location) — Principal executive offices
- 001-40498 (identifier) — Commission File Number
FAQ
What specific listing rule or standard has Century Therapeutics failed to meet?
The filing does not specify the exact listing rule or standard that Century Therapeutics has failed to meet, only that a notice has been issued.
What is the earliest date associated with the reported event?
The earliest event reported is dated February 26, 2025.
When was this Form 8-K filed with the SEC?
This Form 8-K was filed on February 28, 2025.
Where are Century Therapeutics' principal executive offices located?
Century Therapeutics' principal executive offices are located at 25 North 38th Street, 11th Floor, Philadelphia, Pennsylvania, 19104.
What is the company's Commission File Number?
The company's Commission File Number is 001-40498.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 28, 2025 regarding Century Therapeutics, Inc. (IPSC).